Global View Capital Management LLC Purchases Shares of 1,250 HCA Healthcare, Inc. (NYSE:HCA)

Global View Capital Management LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,250 shares of the company’s stock, valued at approximately $372,000.

A number of other hedge funds have also recently bought and sold shares of HCA. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at about $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the third quarter valued at about $41,000. Whipplewood Advisors LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $31,000. Activest Wealth Management grew its position in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after buying an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. grew its position in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 2.0 %

Shares of HCA Healthcare stock opened at $336.60 on Tuesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock has a market capitalization of $82.87 billion, a price-to-earnings ratio of 15.32, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s 50 day moving average price is $317.46 and its 200-day moving average price is $346.96.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company earned $5.90 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Bank of America cut their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Royal Bank of Canada lowered their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Morgan Stanley lowered their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.